The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
作者信息
van Leyen Klaus, Holman Theodore R, Maloney David J
机构信息
Neuroprotection Research Laboratory, Dept. of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
出版信息
Future Med Chem. 2014;6(17):1853-5. doi: 10.4155/fmc.14.129.
Abstract
摘要
相似文献
1
The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
Future Med Chem. 2014;6(17):1853-5. doi: 10.4155/fmc.14.129.
2
Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
Ann Neurol. 2013 Jan;73(1):129-35. doi: 10.1002/ana.23734. Epub 2012 Nov 28.
3
Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Brain Res. 2018 Jan 1;1678:123-128. doi: 10.1016/j.brainres.2017.10.024. Epub 2017 Oct 24.
4
Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
J Neurochem. 2021 May;157(3):586-598. doi: 10.1111/jnc.15308. Epub 2021 Feb 5.
5
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
J Med Chem. 2014 May 22;57(10):4035-48. doi: 10.1021/jm401915r. Epub 2014 May 13.
6
In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Chem Biol Drug Des. 2013 Sep;82(3):317-25. doi: 10.1111/cbdd.12157. Epub 2013 Jun 29.
7
12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.
Stroke. 2017 Feb;48(2):445-451. doi: 10.1161/STROKEAHA.116.014790. Epub 2017 Jan 5.
8
Molecular-dynamics simulation of dioxygen egress from 12/15-lipoxygenase-arachidonic acid complex.
Chem Biodivers. 2012 Jun;9(6):1019-32. doi: 10.1002/cbdv.201100305.
9
Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
Apoptosis. 2014 Apr;19(4):567-80. doi: 10.1007/s10495-013-0946-z.
10
Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2.
Pharmacol Biochem Behav. 2010 Oct;96(4):469-75. doi: 10.1016/j.pbb.2010.07.007. Epub 2010 Jul 14.
引用本文的文献
1
Editorial: The role of inflammation in neurodegenerative and psychiatric disorders.
Front Cell Neurosci. 2025 Mar 11;19:1574274. doi: 10.3389/fncel.2025.1574274. eCollection 2025.
2
Severe Hypothermia Induces Ferroptosis in Cerebral Cortical Nerve Cells.
Int J Mol Sci. 2024 Jul 25;25(15):8086. doi: 10.3390/ijms25158086.
3
Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets.
Cell Mol Neurobiol. 2024 Feb 23;44(1):25. doi: 10.1007/s10571-024-01457-6.
4
The Interplay between Mitochondrial Dysfunction and Ferroptosis during Ischemia-Associated Central Nervous System Diseases.
Brain Sci. 2023 Sep 25;13(10):1367. doi: 10.3390/brainsci13101367.
5
12/15-lipoxygenase inhibition attenuates neuroinflammation by suppressing inflammasomes.
Front Cell Neurosci. 2023 Sep 26;17:1277268. doi: 10.3389/fncel.2023.1277268. eCollection 2023.
6
Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases.
Oxid Med Cell Longev. 2022 Jun 24;2022:9154295. doi: 10.1155/2022/9154295. eCollection 2022.
7
Role of Ferroptosis in Stroke.
Cell Mol Neurobiol. 2023 Jan;43(1):205-222. doi: 10.1007/s10571-022-01196-6. Epub 2022 Jan 31.
8
Baicalein, Baicalin, and Wogonin: Protective Effects against Ischemia-Induced Neurodegeneration in the Brain and Retina.
Oxid Med Cell Longev. 2021 Jun 29;2021:8377362. doi: 10.1155/2021/8377362. eCollection 2021.
9
Ferroptosis and Its Multifaceted Roles in Cerebral Stroke.
Front Cell Neurosci. 2021 Jun 3;15:615372. doi: 10.3389/fncel.2021.615372. eCollection 2021.
10
The Chemical Biology of Ferroptosis in the Central Nervous System.
Cell Chem Biol. 2020 May 21;27(5):479-498. doi: 10.1016/j.chembiol.2020.03.007. Epub 2020 Apr 2.
本文引用的文献
1
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
J Med Chem. 2014 May 22;57(10):4035-48. doi: 10.1021/jm401915r. Epub 2014 May 13.
2
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
3
Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
Ann Neurol. 2013 Jan;73(1):129-35. doi: 10.1002/ana.23734. Epub 2012 Nov 28.
4
Neuroscience networking: linking discovery to drugs.
Neuropsychopharmacology. 2012 Jan;37(1):287-9. doi: 10.1038/npp.2011.177.
5
Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4141-5. doi: 10.1016/j.bmcl.2011.05.107. Epub 2011 Jun 6.
6
Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.
J Med Chem. 2010 Oct 28;53(20):7392-404. doi: 10.1021/jm1008852.
7
Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia.
Stroke. 2008 Sep;39(9):2538-43. doi: 10.1161/STROKEAHA.108.514927. Epub 2008 Jul 17.
8
Novel lipoxygenase inhibitors as neuroprotective reagents.
J Neurosci Res. 2008 Mar;86(4):904-9. doi: 10.1002/jnr.21543.
9
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
Bioorg Med Chem. 2007 Dec 1;15(23):7408-25. doi: 10.1016/j.bmc.2007.07.036. Epub 2007 Aug 22.
10
Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment.
Bioorg Med Chem Lett. 2007 Sep 15;17(18):5115-20. doi: 10.1016/j.bmcl.2007.07.011. Epub 2007 Jul 13.
Zotero 插件